U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Global Alliance for Chronic Diseases Print

Global Alliance for Chronic Diseases

NIH participates in the Global Alliance for Chronic Diseases (GACD), a collection of publicly funded research agencies that supports innovative research collaborations to address the prevention and treatment of chronic diseases in vulnerable populations.

View and filter GACD-supported projects.

Current Funding Opportunities

NCD Multimorbidity Research in LMICs and US Tribal Populations

The current NIH-GACD Funding Opportunity Announcement supports applications that aim to improve the availability of effective, equitable, efficient, integrated, patient-centered, safe, and timely care for people living with multiple long-term conditions (non-communicable disease (NCD) multimorbidity) in low- and middle-income countries (LMICs) and/or within American Indian/Alaska Native (AI/AN) populations in the United States.

NIH funding opportunities supporting this call for applications:

Application due date: The due date for both funding opportunities is February 7, 2025.

Frequently Asked Questions (FAQs)

Watch the Pre-Application Technical Assistance Webinar

Fogarty hosted a pre-application technical assistance webinar to aid potential applicants for the NCD Multimorbidity Research in LMICs and US Tribal Populations (PAR-25-213 and PAR-25-223) on November 12, 2024.

Watch pre-application webinar


Previous Funding Opportunities

TopicFocus
Noncommunicable Disease (NCD) Prevention in Cities
  • Implementation research to reduce the risks of NCDs in the context of cities in low- and middle-income countries (LMICs) and among American Indian/Alaska Native (AI/AN) populations in US cities, with the potential to equip policymakers and practitioners with evidence-based strategies for prevention and/or management of NCDs among disadvantaged populations globally.

Critical Life Stages
  • Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods

Primary and Secondary Prevention of Cancer
  • Primary and secondary prevention of cancer in low- and middle-income countries (LMICs), and in populations facing conditions of vulnerability in high-income countries.

Scaling-up Evidence-based Interventions
  • Scaling-up evidence-based interventions at the population level for the prevention or management of hypertension or diabetes.

Mental Health Research
  • Child, adolescent and adult age onset mental disorders including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders, etc., in low- and middle-income countries and/or in vulnerable populations in high-income countries.

Lung Disease Research
  • Address lung diseases related to environmental exposures , including indoor and outdoor air pollution and tobacco.

Type 2 Diabetes Research
  • Improving the science around implementation of existing interventions for type 2 diabetes.

Hypertension Research
  • Improve the implementation of existing approaches to prevention and control of hypertension.

Related Information & Resources

Related News

Updated December 4, 2024